Latest news & articles

Type 1 Diabetes Prevention: Promising Research Breakthrough Gives New Hope

A research breakthrough, funded by JDRF, has shown a promising future for the prevention of type 1 diabetes. Findings from a study by TrialNet show that the immunotherapy drug teplizumab can delay type 1 diabetes diagnosis a median of 2 years in children and adults at high risk. The study showed that teplizumab interferes with […]